Events

NCBR and BSP Brussels Talks: “Citizens’ engagement in research & innovation”
SEP
Thu
28
09:30 - 11:00

This was 1 year ago

Location

hybrid

NCBR & BSP Office
Rue Belliard 40, 5th floor
(or online)
Programmes
Enhancing EU R&I Missions Horizon Europe

The Polish National Centre for Research and Development (NCBR) and Business and Science Poland (BSP) offices in Brussels organise a talk with Mr. Bruno Maquart, President of the European Network of Science Centres and Museums (ECSITE) and Chairman & CEO of Universcience. The topic of the talk is citizens’ engagement in research & innovation, more specifically in the EU Missions and Horizon Europe, and questions that will be tackled are:

  1. What are the benefits of citizens’ engagement?
  2. How to draw the attention of the EU citizens and engage them in participation in science research and innovation, and in the policy-making processes?
  3. Overloading citizens with surveys and consultations can lead to disengagement. What actions should we consider to avoid citizen fatigue?
  4. How to measure the impact of citizens’ engagement accurately to secure the best quality?
  5. What are the best examples of the activities of the citizens’ engagement based on the ECSITE experience?

Registration for the talk is required by 26 September. In the registration form you can indicate the type of presence (at the venue or online) and submit questions for the speaker.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.